Oncology division

Quote






anonymous said:
Ummm no. They made him move to neurology VP to help get it moving along. Obviously don’t even work here, so why do you care?
Click to expand...
Oh…you are seeing that as a promotion. That’s cute.
Let’s see…oncology is dying, Len is fledgling, so let’s take the sales lead that it is floundering under and send him to ‘turn around’ Neuro?

You definitely work here with that Eisai logic. I do work here and I know TB well. You think he is happy about this? He knows what it is, and will be gone in 6 months or less.

This was a demotion plain and simple. No tenured oncology person wants to ‘drop down’ to what is barely a level(if at all) above primary care.
 






anonymous said:
Oh…you are seeing that as a promotion. That’s cute.
Let’s see…oncology is dying, Len is fledgling, so let’s take the sales lead that it is floundering under and send him to ‘turn around’ Neuro?

You definitely work here with that Eisai logic. I do work here and I know TB well. You think he is happy about this? He knows what it is, and will be gone in 6 months or less.

This was a demotion plain and simple. No tenured oncology person wants to ‘drop down’ to what is barely a level(if at all) above primary care.
Click to expand...
100% true. Well said.
 














































































anonymous said:
Eisai is run more primary care than an actual primary company! I can attest to that. I’ve never been on so many useless calls in my career. Everyone desperately trying to justify their jobs is obvious.
Click to expand...
Unconscious incompetence...they don't know what they don't know. We just grab weak talent from 'insert NJ based pharma company here'...we never get the ex-Genetech, Celegene, types...we can only get marketers and sales personnel that were marketing and selling "speciality drugs" before. Very little have oncology experience. So much so we did an informal survey a little while back on average commercial oncology experience and it was astronomically low when benchmarked to the oncology biotechs.

Len is losing not because of data issues, it is commercial execution and talent. Just listen to earnings calls of our competitors. We actually know this and are unwilling to one shift our culture and two pay what the good companies pay....and this is the outcome.
 






anonymous said:
Unconscious incompetence...they don't know what they don't know. We just grab weak talent from 'insert NJ based pharma company here'...we never get the ex-Genetech, Celegene, types...we can only get marketers and sales personnel that were marketing and selling "speciality drugs" before. Very little have oncology experience. So much so we did an informal survey a little while back on average commercial oncology experience and it was astronomically low when benchmarked to the oncology biotechs.

Len is losing not because of data issues, it is commercial execution and talent. Just listen to earnings calls of our competitors. We actually know this and are unwilling to one shift our culture and two pay what the good companies pay....and this is the outcome.
Click to expand...
Unless our management changes, nothing will change. I heard we talked to a company about buy our oncology.
 












anonymous said:
Unless our management changes, nothing will change. I heard we talked to a company about buy our oncology.
Click to expand...
Agreed, in addition, or you hope that new leadership would work hard to shed the NJ based, big pharma, primary care culture and mentality, and greatly increase the total comp package. If those things happen, Eisai could be far better. Unfortunately, I do not believe there is an appetite for change as they don't see the problems right in front of their faces...or at least they don't want to admit it.
 






Eisai has always been a joke in oncology since the days of Fragmin...never could figure it out. Never could keep the talent they acquired, never could attract top talent in commercial.

They truly believe that oncology is no different than primary care. Liked selling a Bugatti is the same as selling a Yugo...if you tell the PC folks it is different you will irreversibly hurt their fragile feelings, so that is how we make decisions here...
 






Top Bottom
Back
Quote